Apolipoprotein E epsilon 4 allele in Alzheimer's disease and vascular dementia. 1994

G B Frisoni, and L Calabresi, and C Geroldi, and A Bianchetti, and A L D'Acquarica, and S Govoni, and C R Sirtori, and M Trabucchi, and G Franceschini
Alzheimer's Disease Unit, Istituto S. Cuore-FBF, Brescia, Italy.

The frequency of the epsilon 4 allele of the apolipoprotein E (apoE) is increased in familial and sporadic late-onset Alzheimer's disease, but its prevalence in non-Alzheimer dementias in Caucasian populations is unknown. We found that the frequency of the apoE epsilon 4 allele was 0.45 in 93 Alzheimer's disease patients, 0.46 in 23 vascular dementia patients, 0.31 in 13 dementia of the frontal type patients, and 0.18 in 51 elderly controls. The association of apoE epsilon 4 allele is not unique to Alzheimer's disease, and its importance as a risk factor for the disease should be reconsidered.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D001057 Apolipoproteins E A class of protein components which can be found in several lipoproteins including HIGH-DENSITY LIPOPROTEINS; VERY-LOW-DENSITY LIPOPROTEINS; and CHYLOMICRONS. Synthesized in most organs, Apo E is important in the global transport of lipids and cholesterol throughout the body. Apo E is also a ligand for LDL receptors (RECEPTORS, LDL) that mediates the binding, internalization, and catabolism of lipoprotein particles in cells. There are several allelic isoforms (such as E2, E3, and E4). Deficiency or defects in Apo E are causes of HYPERLIPOPROTEINEMIA TYPE III. Apo-E,Apo E,Apo E Isoproteins,ApoE,Apolipoprotein E Isoproteins,Apoprotein (E),Apoproteins E,Isoproteins, Apo E,Isoproteins, Apolipoprotein E
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D015140 Dementia, Vascular An imprecise term referring to dementia associated with CEREBROVASCULAR DISORDERS, including CEREBRAL INFARCTION (single or multiple), and conditions associated with chronic BRAIN ISCHEMIA. Diffuse, cortical, and subcortical subtypes have been described. (From Gerontol Geriatr 1998 Feb;31(1):36-44) Arteriosclerotic Dementia,Binswanger Disease,Encephalopathy, Binswanger,Leukoencephalopathy, Subcortical,Subcortical Arteriosclerotic Encephalopathy,Vascular Dementia,Acute Onset Vascular Dementia,Arteriosclerotic Encephalopathy, Subcortical,Binswanger Encephalopathy,Binswanger's Disease,Chronic Progressive Subcortical Encephalopathy,Encephalopathy, Binswanger's,Encephalopathy, Chronic Progressive Subcortical,Encephalopathy, Subcortical Arteriosclerotic,Encephalopathy, Subcortical, Chronic Progressive,Subcortical Encephalopathy, Chronic Progressive,Subcortical Leukoencephalopathy,Subcortical Vascular Dementia,Vascular Dementia, Acute Onset,Arteriosclerotic Dementias,Arteriosclerotic Encephalopathies, Subcortical,Binswanger's Encephalopathy,Binswangers Disease,Dementia, Arteriosclerotic,Dementia, Subcortical Vascular,Dementias, Arteriosclerotic,Dementias, Subcortical Vascular,Dementias, Vascular,Disease, Binswanger,Disease, Binswanger's,Encephalopathies, Subcortical Arteriosclerotic,Encephalopathy, Binswangers,Leukoencephalopathies, Subcortical,Subcortical Arteriosclerotic Encephalopathies,Subcortical Leukoencephalopathies,Subcortical Vascular Dementias,Vascular Dementia, Subcortical,Vascular Dementias,Vascular Dementias, Subcortical

Related Publications

G B Frisoni, and L Calabresi, and C Geroldi, and A Bianchetti, and A L D'Acquarica, and S Govoni, and C R Sirtori, and M Trabucchi, and G Franceschini
November 1993, Lancet (London, England),
G B Frisoni, and L Calabresi, and C Geroldi, and A Bianchetti, and A L D'Acquarica, and S Govoni, and C R Sirtori, and M Trabucchi, and G Franceschini
November 1993, Lancet (London, England),
G B Frisoni, and L Calabresi, and C Geroldi, and A Bianchetti, and A L D'Acquarica, and S Govoni, and C R Sirtori, and M Trabucchi, and G Franceschini
November 1993, Lancet (London, England),
G B Frisoni, and L Calabresi, and C Geroldi, and A Bianchetti, and A L D'Acquarica, and S Govoni, and C R Sirtori, and M Trabucchi, and G Franceschini
November 1993, Lancet (London, England),
G B Frisoni, and L Calabresi, and C Geroldi, and A Bianchetti, and A L D'Acquarica, and S Govoni, and C R Sirtori, and M Trabucchi, and G Franceschini
November 1993, Lancet (London, England),
G B Frisoni, and L Calabresi, and C Geroldi, and A Bianchetti, and A L D'Acquarica, and S Govoni, and C R Sirtori, and M Trabucchi, and G Franceschini
July 1994, Israel journal of medical sciences,
G B Frisoni, and L Calabresi, and C Geroldi, and A Bianchetti, and A L D'Acquarica, and S Govoni, and C R Sirtori, and M Trabucchi, and G Franceschini
November 1994, Annals of neurology,
G B Frisoni, and L Calabresi, and C Geroldi, and A Bianchetti, and A L D'Acquarica, and S Govoni, and C R Sirtori, and M Trabucchi, and G Franceschini
January 1996, Genetic epidemiology,
G B Frisoni, and L Calabresi, and C Geroldi, and A Bianchetti, and A L D'Acquarica, and S Govoni, and C R Sirtori, and M Trabucchi, and G Franceschini
January 1998, Neuroepidemiology,
G B Frisoni, and L Calabresi, and C Geroldi, and A Bianchetti, and A L D'Acquarica, and S Govoni, and C R Sirtori, and M Trabucchi, and G Franceschini
October 1994, Annals of neurology,
Copied contents to your clipboard!